Medical Software promotes early detection of cancer.
October 13, 2006 -
Computer-Aided Detection (CAD) v7.2 helps radiologists improve screening and workflow by automatically identifying and marking areas typically associated with cancer. Closely aligned with standard mammography training, algorithm marks primary indications of breast cancer in consistent, logical manner. Solution also helps reduce false markings of vascular calcifications and lymph nodes as well as those due to film noise or grain and linear structures.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
|Original Press release |
4 Townsend West St. 17
Nashua, NH, 03063
iCAD Releases Version 7.2 of its Computer-Aided Detection Technology for Mammography
Available Immediately, Version 7.2 Helps Radiologists Improve Screening and Workflow
NASHUA, N.H., Sept. 20 -- iCAD(R), Inc. (NASDAQ:ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early detection of cancer, today announced the release of a new version of its CAD software that will ship with all SecondLook 300 and SecondLook 700 systems.
iCAD's latest software, CAD v7.2, is a highly trained algorithm that automatically identifies and marks areas typically associated with cancer. The CAD software marks the primary indications of breast cancer in a consistent, logical manner that is closely aligned with standard mammography training. The result is an improved workflow for the radiologist and a higher rate of detection among users. In clinical studies, iCAD has been shown to find up to 72% of the cancers that had been missed on the previous mammogram exam.
"Though mammography has come a long way, there is still a need for increased sensitivity," said Rachel Brem, MD, Director of Breast Imaging and Intervention, The George Washington University Medical Center. "iCAD's latest software version has improved sensitivity to subtle cancers with fewer false positives and far more understandable indications. Tests at my facility showed a significant improvement in mass detection. Version 7.2 is a big step forward for iCAD."
CAD v7.2 offers users the following benefits:
o Reduced false markings of vascular calcifications
o Reduced false markings due to film noise or grain
o Reduced false markings of lymph nodes
o Reduced false markings due to linear structures
iCAD uses its patented advanced pattern recognition techniques to see subtle areas of concern. These are then analyzed using the highly trained intelligent computer-aided detection algorithm. iCAD has the ability to delve into each mammographic image in far greater range than the human eye can perceive. This results in iCAD's ability to identify subtle and often overlooked lesions.
"iCAD is committed to continuously innovating and advancing our technology to improve mammography," said Ken Ferry, Chief Executive Officer of iCAD, Inc. "These latest improvements provide radiologists with a more accurate tool, making early detection of breast cancer easier. We are already seeing increased demand from radiologists who realize the benefits of our technology."
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by almost one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com/.